Loading clinical trials...
Loading clinical trials...
Pilot Study, Without Direct Individual Benefice, of Biological Effect of Tarceva (OSI-774) at Posology of 150 mg by Day for Patients Stricken by ENT Epidermoid Carcinoma Waiting for First Surgical Picking up.
Conditions
Interventions
Tarceva
Locations
2
France
Center Oscar Lambret
Lille, France
Institut claudius regaud
Toulouse, France
Start Date
October 1, 2003
Primary Completion Date
December 1, 2006
Completion Date
December 1, 2006
Last Updated
March 27, 2015
NCT06998069
NCT06912087
NCT06303180
NCT05418842
NCT03914378
NCT06003231
Lead Sponsor
Institut Claudius Regaud
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions